Wen Du

Nanjing Normal University — China

Medicine · Health Sciences

20h-index1.0kcitations77works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(19), Pancreatic function and diabetes(19), Chronic Myeloid Leukemia Treatments(11), FOXO transcription factor regulation(11), MicroRNA in disease regulation(9)

Publications77 total

Effect of Weight‐Neutral Treatment With Semaglutide or Tirzepatide on β‐Cell Identity in <i>db</i> / <i>db</i> Mice
Acta Physiologica·2025
Association between a novel obesity indicator and chronic kidney disease as well as depression: A cross-sectional study based on NHANES 2009 to 2014
Medicine·2025Open Access
Exploring the potential ecological risks of cadmium accumulation in coastal sediments: implications for diversity, function, and assembly of fungal community
Journal of Environmental Management·2025
Postbiotic Bifidobacterium. breve 207–1 ameliorates high glucose-induced glycolipid metabolic disorders in C. elegans via the daf-2/daf-16 signaling pathway
Journal of Functional Foods·2025Open Access
Quantitative MRI reveals infrapatellar fat pad changes after running a marathon
PeerJ·2025· 3 citedOpen Access
A Novel High-Effective Diagnostic Model of Chronic Myelogenous Leukemia By Flow Cytometry
Blood·2024
Trajectories of energy from macronutrients and subsequent risk of overweight/obesity among chinese adults: A 28-year follow-up study
Clinical Nutrition ESPEN·2024
Calorie restriction activates a gastric Notch-FOXO1 pathway to expand ghrelin cells
The Journal of Cell Biology·2024· 1 citedOpen Access
Diabetes treatment by conversion of gut epithelial cells to insulin‐producing cells
Journal of Diabetes Investigation·2024· 1 citedOpen Access
Calorie Restriction activates a gastric Notch-FOXO1 pathway to expand Ghrelin cells
2023Open Access
Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure
Nature Communications·2023· 47 citedOpen Access
Cyb5r3-based mechanism and reversal of secondary failure to sulfonylurea in diabetes
Science Translational Medicine·2023· 13 cited
Selective targeting of visceral adiposity by polycation nanomedicine
Nature Nanotechnology·2022· 53 cited
Polycationic PAMAM ameliorates obesity-associated chronic inflammation and focal adiposity
Biomaterials·2022· 24 citedOpen Access
Chemical induction of gut β-like-cells by combined FoxO1/Notch inhibition as a glucose-lowering treatment for diabetes
Molecular Metabolism·2022· 9 citedOpen Access
Pharmacological conversion of gut epithelial cells into insulin-producing cells lowers glycemia in diabetic animals
Journal of Clinical Investigation·2022· 26 citedOpen Access
Single-agent FOXO1 inhibition normalizes glycemia and induces gut β-like cells in streptozotocin-diabetic mice
Molecular Metabolism·2022· 9 citedOpen Access
Reflections on the state of diabetes research and prospects for treatment
Diabetology International·2022· 4 citedOpen Access
Single-agent Foxo1 inhibition normalizes glycemia and induces gut β-like cells in streptozotocin-diabetic mice
2022· 2 citedOpen Access
Cyb5r3-based mechanism and reversal of secondary failure to sulfonylurea
2022Open Access
page 1 of 4Next →

Frequent Co-authors

Shiang Huang(21), Domenico Accili(14), Yanli He(13), Jine Zheng(11), Takumi Kitamoto(11), Xiaoqing Li(10), Wei Liu(10), Yanjie Hu(8), Huiyu Li(7), Junxia Yao(7), Jinsook Son(7), Taiyi Kuo(7), Sandro Belvedere(7), Xiangjun Chen(6), Wendy M. McKimpson(6), Hitoshi Watanabe(6), Yun‐Kyoung Lee(6), Nishat Sultana(6), Bryan Diaz(6), Jason Fan(5)